Skip to content

SAT PRWire

  • Business
  • Technology
  • Health
  • Science

Category: News

Indonesia Tsunami: 281 killed in tsunami in Indonesia, 1000 injured

Indonesia Tsunami: 281 killed in tsunami in Indonesia, 1000 injured

December 24, 2018Colin Walker

The tsunami has created a catastrophe in Indonesia (Indonesia Tsunami). Wasting storm waves from the volcano erupted have snatched hundreds of lives. So far the figure of those who have died has reached 281. While more than a thousand people have been injured, this waste came after the eruption of the volcano in Curator. Many […]

Continue Reading

Posts navigation

Newer posts

Recent Posts

  • James Webb Telescope Captures First-Ever Photo of Interstellar Comet 3I ATLAS

    James Webb Telescope Captures First-Ever Photo of Interstellar Comet 3I/ATLAS

    September 2, 2025Mary Adams
  • China: the mystery of the herd of sheep going around in circles

    China: the mystery of the herd of sheep going around in circles

    November 29, 2022Ben Parker
  • New Product Launches and Investments to Boost Dermocosmetics Business

    New Product Launches and Investments to Boost Dermocosmetics Business

    November 14, 2022Ben Parker
  • Majority of people feel socially connected as Covid-19 ease but others still needs support, survey reveals

    Majority of people feel socially connected as Covid-19 ease but others still needs support, survey reveals

    October 28, 2022Axiom
  • ScPharmacueticals’ Heart Failure Therapy Approved By US FDA

    ScPharmaceuticals’ Heart Failure Therapy Approved By US FDA

    October 11, 2022Axiom
  • UK To Offer Second Vaccine Doses To People At High-Risk From Monkeypox

    UK To Offer Second Vaccine Doses To People At High-Risk From Monkeypox

    September 30, 2022Axiom
  • Theranica, a digital therapeutics company, has conducted a study comparing the effectiveness of Remote Electrical Neuromodulation (REN) to standard-care medications for the acute treatment of chronic migraine. The study concludes that REN, administered by the flagship therapeutic wearable of Theranica, provides an effective non-pharmaceutical alternative to the standard-care abortive medications in individuals affected by chronic migraine. Brian Grosberg, director of the Hartford Healthcare Headache Program, said chronic migraine is a disabling condition, which is diagnosed when a migraine patient experiences at least 12 headache days per month. According to Brian Grosberg, the recent consensus statement of the American Headache Society recommends that, to avoid medication overuse, patients with migraine should be instructed to limit medication use to two headache days per week. Brian Grosberg said that chronic migraine patients often have four, five, or six headache days per week. To treat patients effectively and safely, they should expand the first-line standard-care treatment options beyond the medications. The study also provides a strong comparison of REN to prescribed medications, further reinforcing the conclusion that REN provides a much-needed alternative to acute migraine treatment without compromising the effectiveness of the treatment.

    REN Comparable To Standard-Care Prescribed Medications To Treat Chronic Migraines

    September 21, 2022Axiom
  • In China, students are now monitored using their pen

    In China, students are now monitored using their pen

    August 29, 2022Mary Adams
Copyright © 2022, All Rights Reserved. | Theme: News Portal by Mystery Themes.
  • About Us
  • Privacy Policy
  • Contact Us